Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,889 shares at $32.89 ($621,259)
  2. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 17,000 shares at $32.35 ($549,950)
  3. 4 Option exercise Director acquired 64,508 shares (option exercise)
  4. 4 Planned sale CHIEF OPERATING OFFICER sold 18,900 shares at $28.72 ($542,808)
  5. 4 Option exercise Director acquired 1,101 shares (option exercise)
  6. 4 Planned sale CHIEF OPERATING OFFICER sold 17,300 shares at $28.28 ($489,244)
  7. 4 Open-market sale Director sold 27,448 shares at an average $30.35 ($833,001)
  8. 4 Planned sale CHIEF OPERATING OFFICER sold 70,867 shares at an average $30.48 ($2,160,035)
  9. 4 Option exercise Director acquired 3,173 shares (option exercise)
  10. 4 Grant or award Director acquired 16,794 shares (grant or award)
  11. 4 Option exercise Director acquired 3,173 shares (option exercise)
  12. 4 Option exercise Director acquired 3,173 shares (option exercise)
  13. 4 Option exercise Director acquired 3,173 shares (option exercise)
  14. 4 Option exercise Director acquired 3,173 shares (option exercise)
  15. 4 Option exercise Director acquired 3,173 shares (option exercise)
  16. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 15,211 shares at $28.75 ($437,316)
  17. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 27,594 shares at $29.02 ($800,778)
  18. 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,299 shares at $28.80 ($527,011)
  19. 4 Planned sale CHAIRMAN & CEO sold 86,270 shares at an average $27.24 ($2,349,981)
  20. 4 Planned sale CHAIRMAN & CEO sold 2,349 shares at $27.02 ($63,470)

Page 5 of 20 · 386 filings